HKD 1.84
(-0.54%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 91.47 Million CNY | 129.71% |
2022 | -307.88 Million CNY | -180.89% |
2021 | 380.61 Million CNY | -66.11% |
2020 | 1.12 Billion CNY | 103.99% |
2019 | 550.47 Million CNY | 37.99% |
2018 | 398.91 Million CNY | -42.25% |
2017 | 690.79 Million CNY | 25.0% |
2016 | 552.61 Million CNY | 479.8% |
2015 | -145.5 Million CNY | -209.58% |
2014 | 132.78 Million CNY | -78.06% |
2013 | 605.13 Million CNY | 29.64% |
2012 | 466.77 Million CNY | 15.32% |
2011 | 404.76 Million CNY | 52.1% |
2010 | 266.12 Million CNY | 9.94% |
2009 | 242.07 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 154.05 Million CNY | 0.0% |
2023 Q2 | 26.12 Million CNY | 0.0% |
2023 FY | 91.47 Million CNY | 129.71% |
2023 Q4 | 65.35 Million CNY | 0.0% |
2022 Q4 | -245.19 Million CNY | 0.0% |
2022 FY | -307.88 Million CNY | -180.89% |
2022 Q2 | -62.68 Million CNY | 0.0% |
2021 FY | 380.61 Million CNY | -66.11% |
2021 Q4 | 52.99 Million CNY | 0.0% |
2021 Q2 | 327.62 Million CNY | 0.0% |
2020 Q2 | 373.66 Million CNY | 0.0% |
2020 Q4 | 749.27 Million CNY | 0.0% |
2020 FY | 1.12 Billion CNY | 103.99% |
2019 Q4 | 516.44 Million CNY | 0.0% |
2019 Q2 | 32.27 Million CNY | 0.0% |
2019 FY | 550.47 Million CNY | 37.99% |
2018 FY | 398.91 Million CNY | -42.25% |
2018 Q2 | 244.29 Million CNY | 0.0% |
2018 Q4 | 154.61 Million CNY | 0.0% |
2017 FY | 690.79 Million CNY | 25.0% |
2017 Q2 | 181.6 Million CNY | 0.0% |
2017 Q4 | 509.19 Million CNY | 0.0% |
2016 Q2 | 176.75 Million CNY | 0.0% |
2016 FY | 552.61 Million CNY | 479.8% |
2016 Q4 | 375.85 Million CNY | 0.0% |
2015 Q4 | -248.46 Million CNY | 0.0% |
2015 FY | -145.5 Million CNY | -209.58% |
2015 Q2 | 102.96 Million CNY | 0.0% |
2014 FY | 132.78 Million CNY | -78.06% |
2014 Q4 | 26.95 Million CNY | 0.0% |
2014 Q2 | 105.83 Million CNY | 0.0% |
2013 Q4 | 278.94 Million CNY | 0.0% |
2013 Q2 | 326.18 Million CNY | 0.0% |
2013 FY | 605.13 Million CNY | 29.64% |
2012 Q1 | 116.75 Million CNY | 0.0% |
2012 Q3 | 116.75 Million CNY | 0.0% |
2012 Q2 | 116.75 Million CNY | 0.0% |
2012 Q4 | 151.19 Million CNY | 29.5% |
2012 FY | 466.77 Million CNY | 15.32% |
2011 Q4 | 116.75 Million CNY | 15.26% |
2011 Q2 | 101.29 Million CNY | 0.0% |
2011 FY | 404.76 Million CNY | 52.1% |
2011 Q3 | 101.29 Million CNY | 0.0% |
2011 Q1 | 101.29 Million CNY | 0.0% |
2010 FY | 266.12 Million CNY | 9.94% |
2010 Q3 | 66.57 Million CNY | 0.0% |
2010 Q4 | 101.29 Million CNY | 52.15% |
2010 Q1 | 66.57 Million CNY | 0.0% |
2010 Q2 | 66.57 Million CNY | 0.0% |
2009 Q2 | 65.04 Million CNY | 0.0% |
2009 FY | 242.07 Million CNY | 0.0% |
2009 Q3 | 65.04 Million CNY | 0.0% |
2009 Q4 | 66.57 Million CNY | 2.36% |
2009 Q1 | 65.04 Million CNY | 0.0% |
2008 Q4 | 65.04 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Wai Chun Bio-Technology Limited | -15.43 Million HKD | 692.736% |
Lee & Man Chemical Company Limited | 400.66 Million HKD | 77.169% |